TSBX Valuation

Turnstone Biologics Corp

Add to Watchlist

Advanced Chart

0.360

-0.002(-0.553%)1D

Overview
Forecast
Valuation
Earnings

TSBX Relative Valuation

TSBX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TSBX is overvalued; if below, it's undervalued.

Historical Valuation

Turnstone Biologics Corp (TSBX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -0.83. The fair price of Turnstone Biologics Corp (TSBX) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：0.36

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.42

P/B

Median3y

0.42

Median5y

0.42

-694.36

FCF Yield

Median3y

-338.92

Median5y

-338.92

Competitors Valuation Multiple

The average P/S ratio for TSBX's competitors is 15.74, providing a benchmark for relative valuation. Turnstone Biologics Corp Corp (TSBX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

TSBX.O

Turnstone Biologics Corp

Loss

Average P/S: 15.74

8.33M